NCT04700553

Brief Summary

Background and objectives: Lower extremity functional impairments are common consequences of stroke. Thus, continuous examination of effective treatment interventions for lower extremity functions after stroke is a necessity. Localized muscle vibration (LMV) is one of the treatment interventions that incorporate sensory stimulation to improve motor cortical excitability. This study aimed to investigate the influences of 10-minutes lower extremity LMV application along with conventional physical therapy (CPT) on activities of daily living (ADL) and motor recovery on the hemiparetic lower extremity post-stroke. Methods: A sample of 37 patients with stroke (8 females) was randomly allocated to either conventional physical therapy (CPT) control group (n=18) or conventional physical therapy and localized muscle vibration (CPT+LMV) experimental group (n=19). All patients received 3 sessions per week of CPT for 8 weeks. The CPT+LMV experimental group received 10-minute LMV at the end of each CPT session. The outcome measures used were the Barthel Index (BI), Berg Balance Scale (BBS), and goniometry for Range of Motion (ROM) assessment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 1, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 8, 2021

Completed
2.5 years until next milestone

Study Start

First participant enrolled

July 1, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

June 13, 2023

Status Verified

June 1, 2023

Enrollment Period

2 months

First QC Date

January 1, 2021

Last Update Submit

June 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Barthel Index (BI)

    The Barthel Index of Activities of Daily Living (BI). Measure of functional disability. The BI consisting of 10 common activities of daily living (ADL) activities, administered through direct observation. These are assessed for independence/ dependence and scored via an arbitrary weighting system (originally applied to reflect nursing care and social acceptability). Eight of the ten items represent activities related to personal care; the remaining 2 are related to mobility. The index yields a total score out of 100 - the higher the score, the greater the degree of functional independence

    Change from baseline activity of daily livings at 8 weeks

Secondary Outcomes (4)

  • Berg Balance Scale

    Change from baseline balance at 8 weeks

  • Goniometry

    Change from baseline range of motion at 8 weeks

  • Manual Muscle Testing

    Change from baseline range of motion at 8 weeks

  • Modified Ashworth Scale

    Change from baseline range of motion at 8 weeks

Study Arms (2)

Conventional physical therapy intervention plus localized muscle vibration

EXPERIMENTAL

physical therapy intervention plus localized muscle vibration

Device: Localized muscle vibrationOther: Conventional physiotherapy intervention

Conventional physical therapy intervention

SHAM COMPARATOR

physical therapy intervention

Other: Conventional physiotherapy intervention

Interventions

All patients in both experimental and control groups received CPT protocol consisted of 30 minutes of manual resistance exercise (3 sets/10 repetitions each for knee extensors and flexors) and 30 minutes of treadmill training, short breaks (1-5 minutes) were allowed, depending on the patient tolerance. The training was conducted for 3 days per week for 8 weeks. The patients in CPT+LMV experimental group received localized muscle vibration at the end of each CPT session. The LMV was applied for 5 minutes perpendicularly along quadriceps muscle fibers. The frequency set at 30 Hz, amplitude of 2 mm.

Also known as: manual resistance exercise, treadmill training
Conventional physical therapy intervention plus localized muscle vibration

All patients in both experimental and control groups received CPT protocol consisted of 30 minutes of manual resistance exercise (3 sets/10 repetitions each for knee extensors and flexors) and 30 minutes of treadmill training, short breaks (1-5 minutes) were allowed, depending on the patient tolerance. The training was conducted for 3 days per week for 8 weeks. The patients in CPT+LMV experimental group received localized muscle vibration at the end of each CPT session. The LMV was applied for 5 minutes perpendicularly along quadriceps muscle fibers. The frequency set at 30 Hz, amplitude of 2 mm.

Also known as: manual resistance exercise, treadmill training
Conventional physical therapy interventionConventional physical therapy intervention plus localized muscle vibration

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed diagnosis of stroke

You may not qualify if:

  • If they had any serious orthopedic injury/disease, cardiopulmonary problems or suffered from a neurological disease (other than stroke).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Policlinico Tor Vergata

Rome, RM, 00133, Italy

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Giuseppe Annino, PhD

    University of Rome Tor Vergata

    STUDY DIRECTOR

Central Study Contacts

Anas R Alashram, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 1, 2021

First Posted

January 8, 2021

Study Start

July 1, 2023

Primary Completion

August 31, 2023

Study Completion

August 31, 2023

Last Updated

June 13, 2023

Record last verified: 2023-06

Locations